Generic Name ADALIMUMAB-ATTO Review Date Began Tue, 05/23/2023 - 12:00 Review Date Completed Wed, 07/05/2023 - 12:00 Conclusion PDL Product Committee Month Sun, 10/01/2023 - 12:00